Stocks snap 4-day winning streak as coronavirus vaccine, treatment hit snags

/ / News

Stocks ended lower Tuesday, snapping a four-day winning streak for major indexes, as investors weighed separate setbacks in trials for a COVID-19 vaccine and a treatment and sifted through earnings for big Wall Street banks. The Dow Jones Industrial Average fell around 157 points, or 0.5%, to end near 28,681, while the S&P 500 gave up around 22 points, or 0.6%, finishing near 3,512. The Nasdaq Composite closed near 11,864, down 97 points, or 0.8%. Shares of Johnson & Johnson fell 2.9% after Stat News reported that the drug maker had paused its COVID-19 vaccine trial over an “unexplained illness.” Later Tuesday, Eli Lilly & Co. confirmed that a data safety monitoring board had paused enrollment in a clinical study testing its experimental COVID-19 monoclonal antibody treatment in combination with Gilead Sciences Inc.’s remdesivir. Eli Lilly shares ended 2.9% lower.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.